Status:
COMPLETED
Comparison of Two Different Pelvic Floor Muscle Training Programs in Stress Urinary Incontinence
Lead Sponsor:
Hacettepe University
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Pelvic floor muscle training (PFMT) is indicated as a first-line treatment for stress urinary incontinence. PFMT aims to improve pelvic floor muscle strength, endurance and relaxation ability or a com...
Detailed Description
Our study is designed as a parallel group, randomized clinical trial. Participants who meet the inclusion criteria will be assigned randomly to one of the study groups. The participants in the 1st gro...
Eligibility Criteria
Inclusion
- Patients suffering from stress urinary incontinence or SUI predominant Mixed Urinary Incontinence according to the 3 Incontinence Questionnaire (3IQ)
- Body mass index \<35 kg/m²
- Individuals over the age of 18 (with a Mini Mental Test score ≥ 24 for individuals over the age of 65)
Exclusion
- Patients with pure urge incontinence, urge predominant mixed urinary incontinence or neurogenic bladder
- Pregnancy or suspected of pregnancy
- Those who have given birth in the last 1 year
- Being virgin
- Those who have had abdomino-pelvic surgery in the last 6 months, and/or those who have received abdomino-pelvic radiotherapy
- Those with urinary tract infection, recurrent urinary tract infection, diagnosis of interstitial cystitis
- Any orthopedic problem that will hinder exercise
- Patients over 65 years of age with a mini mental test score \< 24
- Patients with Pelvic Organ Prolapse grade ≥ Stage 2
- Those who have received treatment for urinary incontinence in the last 6 months
- Those who have uncontrolled diabetes and hypertension, severe systemic disease
- Those who have a neurological disease that will affect the urinary system
- Those who have started a new drug that will affect bladder functions in the last 1 month
- The strength of the pelvic floor muscles in digital examination is \<2 according to the Modified Oxford Scale score.
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05293886
Start Date
November 15 2021
End Date
April 30 2023
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Berna Tokmak
Ankara, Turkey (Türkiye), 06100